05:04 PM EDT, 08/20/2025 (MT Newswires) -- Scott Dreyer, Executive Vice President & Chief Commercial Officer, on August 18, 2025, sold 16,389 shares in Collegium Pharmaceutical ( COLL ) for $626,171. Following the Form 4 filing with the SEC, Dreyer has control over a total of 103,613 common shares of the company, with 103,613 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/xslF345X05/form4.xml